HRT pills, patches and heart disease risk factors

May 16, 2001

University Park, Pa. --- The different effects of oral vs. transdermal hormone replacement therapy (HRT) on heart disease risk factors make a woman's choice between taking estrogen via pill or patch more than a convenience issue, says a Penn State researcher.

Dr. Sheila West, assistant professor of biobehavioral health, is lead author of a new study, which is one of the first to look at the effects of the estrogen pill vs. the patch on heart disease risk factors beyond blood pressure and cholesterol.

The study results showed that the HRT pill and patch had similar positive effects on the tightness or constriction of blood vessels, total cholesterol and low-density lipoprotein cholesterol (LDLs, the "bad" cholesterol). However, the research team found different effects on high density lipoprotein (HDLs, the "good" cholesterol) and triglycerides depending on whether the woman was taking HRT pills or using a patch to deliver estrogen.

In addition, the study found that women who used either the estrogen pill or the patch had lower blood pressure during psychological stress. West says this blood pressure lowering effect might be a new way to explain how estrogen protects women from heart disease.

"Women may have special reasons for wanting to choose the patch or the estrogen pill," says the Penn State researcher. "If, for example, a woman has low HDLs, she might choose oral HRT since subjects in our study and other studies showed no change in the beneficial HDLs while on transdermal therapy. "On the other hand, a woman might want to select the patch if her triglycerides were already high, since oral therapy increases this factor which is associated with a higher risk of heart disease." The study is detailed in the April issue of the American Journal of Obstetrics and Gynecology in a paper, "Transdermal Estrogen Reduces Vascular Resistance and Serum Cholesterol in Postmenopausal Women." West conducted the study as part of her dissertation when she was a doctoral student at the University of North Carolina at Chapel Hill. Her co-authors are University of North Carolina, Chapel Hill, faculty members Dr. Alan L. Hinderliter, associate professor of medicine; Dr. Ellen C. Wells, associate professor of medicine; Dr. Susan S. Girdler, assistant professor of psychiatry; and Dr. Kathleen C. Light, professor of psychiatry.

In their paper, the researchers write, "Trials to examine whether HRT reduces risk of morbidity and mortality in women without preexisting coronary disease are not yet available. Furthermore, the relatively recent introduction of the estrogen patch means that its long-term impact on the risk of coronary events in postmenopausal women is also unknown. Until the appropriate longitudinal studies can be completed, randomized clinical trials examining multiple markers of coronary risk are critical to establish the efficacy of novel hormone preparations."

The primary goal of the researchers' study was to compare changes in multiple cardiac risk factors in healthy women receiving HRT via either the pill or the patch. The researchers compared 10 postmenopausal women receiving HRT via the Estraderm patch with 23 women taking an estrogen pill, Premarin, for six months. Nine subjects received placebos. The women who used the estrogen patch also took progesterone via pill, Cycrin. The estrogen pill takers also received progesterone. The subjects were tested for cardiovascular responses during rest and under stress before they began taking the medication and again after three and six months of treatment. The researchers looked at the subjects' responses both during rest and under stress because there have been recent reports that HRT decreases cardiovascular reactivity to psychological stress.

The stressors included describing a recent life experience which caused stress or anger, two challenging cognitive tests, and a physical stressor in which a bag of ice and cold water was held on the forehead for four minutes.

The team's results confirmed earlier studies which showed that both HRT pill and patch therapy lowers blood pressure during psychological stress.

In addition, the study was the first to show that the ability of the blood vessels to relax increases with both estrogen pills and patches and that this relaxation response persists even when the subjects were under stress.

"The study shows that the patch and the pill equally impact the risk factors studied, except for HDLs and triglycerides," West notes. "The estrogen pill seems to elevate the triglycerides while the patch does less so. Oral estrogen also increases HDLs while the transdermal patch does not. "It remains to be seen, perhaps in a larger study, whether the effect on HDLs means women are not equally protected by the patch and the pill," she says.
-end-
Support for the study came from the National Institutes of Health; the General Clinical Research Center at the University of North Carolina, Chapel Hill; the National Institutes of Mental Health; the St. Anthony Educational Foundation, Ithaca, N.Y.; and Wyeth Ayerst.

EDITORS: Dr. West is 814-863-0176 or sgw2@psu.edu by email.

Penn State

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.